Cadherins, a family of Ca 2+ -dependent cell adhesion molecules, play an important role in ovarian tissue remodelling processes. The aim of this study was to examine the expression pattern of E-and N-cadherin in rat preovulatory follicles, luteinizing follicles and corpora lutea. Immature female rats were treated with equine chorionic gonadotrophin (eCG) to promote preovulatory follicle development. At 48 h after eCG treatment, the rats were injected with an ovulatory dose of hCG. Ovaries were analysed by western blot analysis and immunofluorescence for E-and N-cadherin expression at 48 h after eCG injection, and at 24 and 72 h after hCG injection. Ovaries of cyclic adult rats were examined to assess whether the changes in the expression pattern of cadherin were in agreement with those of the gonadotrophintreated rats. Finally, expression of E-cadherin in luteinizing granulosa cells in vitro was assessed by RT-PCR and western blot analysis. Immunofluorescence results indicate that E-cadherin is expressed in the theca-interstial cells surrounding preovulatory follicles. N-cadherin expression is prominent in the membrana granulosa of these follicles. The initiation of luteinization with hCG leads to a decreased expression of N-cadherin in the membrana granulosa, whereas expression of E-cadherin starts within the luteinizing follicle. Both cadherins are prominently expressed in the fully formed corpus luteum at 72 h after hCG treatment. Immunofluorescence results revealed that the patterns of E-and N-cadherin expression in the gonadotrophin-treated rats were similar to those of the cyclic adult rats. Western blot analysis reflected similar changes for N-cadherin in the ovaries of both the cyclic adults and gonadotrophin-treated rats; however, they were different in E-cadherin expression. The expression of E-cadherin mRNA and protein was induced in vitro in luteinized granulosa cells. These results support the hypothesis that modulation of cadherin expression is an integral component of remodelling processes, including corpus luteum formation, in the ovary. The results also indicate that expression of E-and N-cadherin in granulosalutein cells appear to be under hormonal control.
Introduction
Cell interactions and rearrangements are an important aspect of ovarian function and structure (Hirshfield, 1991; Richards et al., 1995) . Although the ovarian follicle undergoes extensive remodelling during its growth and development, particularly marked changes in follicular structure and function are seen after ovulation and corpus luteum formation (Murphy, 2000) . Over the periovulatory period the basement membrane of the follicle degenerates allowing theca cells and vascular elements, as well as connective tissue cells, to invade the previously avascular membrana granulosa (Van Blerkom and Motta, 1978; Mori et al., 1983 ; for a review, see Murphy, 2000) .
The subsequent consolidation of these cells results in a functional corpus luteum.
The characteristics of both the theca and granulosa cells change markedly during luteinization. The cells increase in size, acquire a polyhedral shape, accumulate lipids and produce increased amounts of progesterone (Van Blerkom and Motta, 1978; Mori et al., 1983) . In some species, including humans, the theca-and granulosa-lutein cells are separated in layers and can be distinguished from one another (Greenwald and Rothchild, 1968; Mori et al., 1983) . However, in rats the two types of luteal cells become intermingled as early as 36 h after ovulation (Pedersen, 1951; Greenwald and Rothchild, 1968) . Clearly, changes in cell adhesion molecules (CAMs) must occur during this remodelling process to permit the migration of theca cells and to facilitate the association of luteinizing theca and granulosa cells into a functional corpus luteum.
The cadherins are a family of calcium-dependent CAMs that have been studied extensively for their role in embryogenesis and organogenesis, as well as in cell sorting and migration (Nose et al., 1988; Friedlander et al., 1989; Radice et al., 1997a,b; Simonneau and Thiery, 1998; Vallin et al., 1998) . A number of studies have demonstrated that cadherins are important regulators of reproductive tissue structure, function and viability (Peluso, 1997; Makrigiannakis et al., 2000; Peluso, 2000; reviewed by Rowlands et al., 2000) . Trolice et al. (1997) have shown that N-cadherin is involved in maintaining the viability of granulosa cells in rats. Cell adhesion affects the ability of rat granulosa cells to acquire LH receptors (Farookhi and Desjardins, 1986 ) and also influences their responsiveness to gonadotrophin signals (Harandian and Farookhi, 1998) . Thus, cadherins can affect the survival, differentiation and function of ovarian cells.
Previous studies focused on the developmental expression and distribution of the classic cadherins, E-and N-cadherin, in the prepubertal rat ovary (Machell et al., 2000) . More recently, it has been shown that additional cadherins, specifically P-, K-and OB-cadherin, are expressed in the prepubertal rat ovary and they too display distinct developmental localization (Machell et al., 2002) . One marked feature of follicular cadherin expression is the absence of E-cadherin from the membrana granulosa of large preantral and antral follicles and the presence of this CAM in theca cells (Machell et al., 2000) . In contrast, expression of N-cadherin is maintained in the membrana granulosa at all stages of follicle development, including large antral follicles, and is present in the theca-interstitium (Machell et al., 2002) . Sundfeldt et al. (2000) reported that there was a decrease in the expression of ovarian E-cadherin after induction of ovulation with hCG in equine chorionic gonadotrophin (eCG)-primed rats. Together, these findings raise the question of what happens to the expression of these CAMs in the periovulatory period and during corpus luteum formation and establishment. In an attempt to address this issue, the expression of E-and N-cadherin was examined in ovaries of gonadotrophin-treated immature rats. Ovaries of adult cyclic rats were examined on each day of the oestrous cycle to assess changes in the expression of cadherin under endogenous hormonal conditions. Finally, changes in cadherin expression were examined in isolated granulosa cells undergoing luteinization in vitro.
Materials and Methods

Animals
All animal care and experimental treatments followed the regulations established by the Canadian Council on Animal Care and were approved by the Animal Care Committee of the Royal Victoria Hospital (Montreal, QC). Female Sprague-Dawley rats were purchased from Charles River (St Constant, QC) and housed under a 12 h light : 12 h dark photoperiod with food and water available ad libitum.
Gonadotrophin-treated rats
In vivo luteinization. Twelve immature rats of 22 days of age were injected s.c. with 10 iu eCG (Equinex, Ayerst Laboratories, Montreal, QC) in PBS containing 0.1% (w/v) gelatin (PBS-GM). An additional four control rats were injected with an equivalent volume (0.1 ml) of PBS-GM. After 48 h, four eCG-treated rats were killed by exposure to CO 2 and their ovaries recovered. One ovary from each animal was frozen on dry ice and stored at -80 • C until processed for protein extraction. The other ovary was fixed in cold 100% methanol, post-fixed in 70% ethanol and then embedded in paraffin wax. The remaining eight eCG-treated rats were injected s.c. with 10 iu hCG (APL, Ayerst Laboratories) in PBS-GM. The four control (PBS-GM injected) rats received another injection at the same time with PBS-GM (0.1 ml). At 24 h after administration of hCG, four of the rats treated with eCG and hCG were killed and their ovaries allocated and processed as described above. At 72 h after the administration of hCG, the remaining four rats treated with eCG and hCG were killed. The four control rats (PBS-GM-injected) were killed at the same time. The ovaries from these two groups of animals were allocated and processed as described above.
In vitro luteinization. Sixteen rats of 22 days of age were injected s.c. with 10 iu eCG in PBS-GM. After 48 h, eight animals were killed and granulosa cells were isolated from their ovaries. Cells were obtained by first puncturing the large preovulatory follicles with a 27-gauge syringe needle and then gently pressing on the ovary with a microscalpel to expel the cells. The granulosa cells were collected in PBS and aliquots of the cell suspension were assessed for cell viability by Trypan blue exclusion. Cells with 60-70% viability were routinely recovered. Cells derived from the ovaries of each animal were maintained separately.
The isolated granulosa cells were plated in 35 mm culture dishes in 1 ml of Dulbecco's modified Eagle's medium and Ham's F12 (1:1 v:v) media containing penicillin (100 U ml −1 ) and streptomycin (100 g ml − 1 ). Cells were plated at a density of 500 000 cells per dish and cultured either in the absence or presence of hCG (1 iu ml − 1 ). At least two dishes per treatment ( ± hCG) were established using cells derived from a single animal. Media were removed at 24 h intervals for progesterone analysis and replaced with fresh media. Cell cultures were maintained for 3 days after which cells were washed with fresh media and harvested by scraping with a rubber policeman. The cell suspensions were centrifuged at 800 g for 5 min and the resulting cell pellets frozen for either protein or RNA extraction.
Granulosa cells from the remaining eight eCG-treated rats and from eight age-matched rats that received PBS-GM were collected as controls to compare cadherin expression with that of the cultured granulosa cells. Granulosa cells were collected from the large preovulatory follicles of the ovaries from eCG-treated rats and from the surface follicles of rats that received PBS-GM. As described previously, cells from both ovaries of a single animal were collected and maintained as a separate sample. The residual ovarian tissue, after granulosa cell isolation, was collected from rats that received PBS-GM. The granulosa cells and residual ovarian tissue were washed in PBS and flash frozen for later protein or RNA extraction.
Cyclic adult rats
Adult cyclic female rats were approximately 50 days of age on arrival. Only animals showing regular 4-day cycles, as assessed over a 3 week period, were used. Oestrous cycles were monitored each day by examination of vaginal smears. Groups of rats were killed on the morning of each day of the oestrous cycle. The ovaries were dissected and then either frozen on dry ice and stored at -80 • C until processed for protein extraction (four to five rats per group) or fixed for tissue sectioning (three rats per group) as described above.
Protein extraction
Ovaries. Frozen whole ovaries were pulverized on dry ice and processed for protein extraction as crude membrane preparations (Machell et al., 2000) . Briefly, cold extraction buffer (10 mmol Tris l − 1 , pH 7.4, with 1 mmol CaCl 2 l − 1 and 1 g ml − 1 of protease inhibitors: pepstatin A, phenylmethylsulphonyl fluoride, leupeptin, soybean trypsin inhibitor and aprotinin) and solubilization buffer (18.75 mol; final concentrations of 62.5 mmol Tris l − 1 , pH 6.8, 2% (w/v) SDS, 10% (v/v) glycerol, and 5% (v/v) ␤-mercaptoethanol) were added to the pulverized ovaries. The extracts were sonicated and centrifuged (10 000 g for 10 min) to remove insoluble material. The supernatants were centrifuged at high speed (100 000 g for 1 h at 4 • C) and the resultant pellets resuspended in solubilization buffer and heated for 5 min at 100 • C.
Isolated cells and residual ovarian tissue
Owing to the small amount of material recovered from cells luteinized in vitro, the granulosa cells and residual ovarian tissue were prepared as total protein extracts. The cells were extracted as described above except that the centrifugation at 10 000 g was eliminated. The protein content of all samples was assayed as described by Machell et al. (2000) .
SDS-PAGE and western blot analysis
Protein samples were resolved by SDS-PAGE and blotted as described by Machell et al. (2000) . Four micro-grams of protein of crude membrane preparations from whole ovaries and 20 g protein of total extracts from granulosa cells or residual ovarian tissue were loaded on to the gels. An ovary extract from a pro-oestrous rat was included on each gel to allow standardization between gels (Machell et al., 2000) . Membranes were immersed in 0.2% (w/v) blocking reagent (Roche Diagnostics, Laval, QC) for 1 h at room temperature (20 • C) and incubated overnight at room temperature with mouse monoclonal antibodies against either E-cadherin (clone 36) (Transduction Laboratories; Bio/Can Scientific, Missisauga, ON) or N-cadherin (Zymed Laboratories Inc., San Francisco, CA), diluted 1:125 and 1:150, respectively. Alkaline phosphatase-conjugated second antibodies (rabbit anti-mouse IgG, Bio/Can Scientific) diluted 1:2500 in blocking reagent were incubated with the membranes for 2 h at room temperature. The results were visualized using a chemiluminescent detection system (Bio/Can Scientific Inc., Mississauga, ON).
Immunofluorescent staining
Immunofluorescent staining for E-and N-cadherin was performed as described by Machell et al. (2000) . Specificity of the antibodies has been demonstrated by Machell et al. (2000) . Sections incubated with either nonspecific mouse IgG antibodies (Cedarlane Laboratories Ltd., Hornby, ON) or with the fluorescent second antibody alone served as negative controls. Images were captured using an image analysis computer system (Applied Imaging, Pittsburgh, PE) attached to an Olympus BX60 fluorescence microscope.
RNA extraction and RT-PCR
RNA was extracted from frozen ovaries, residual ovarian tissue and granulosa cells as described by Machell et al. (2000) . Reverse transcription and PCR were performed using primers specific for E-cadherin as described by Machell et al. (2000) . PCR products were resolved on 1.5% (w/v) agarose gels and visualized after ethidium bromide staining.
Progesterone assay
Functional luteinization of granulosa cells was assessed by measurement of the progesterone content of the media collected from the cell cultures. Progesterone was assayed using the progesterone enzymeimmunoassay test kit (ICN Pharmaceuticals, Orangeburg, NY) by following the manufacturer's instructions.
Statistical analysis
Densitometric analysis of scanned films was used to quantify the western blots. Absorbance values of all bands were normalized to the value obtained for the Percentage of mean peak value Percentage of mean peak value The bottom panels are graphical representations derived from the densitometric analyses of similar western blots from four separate groups of rats treated in a similar way. Densitometric values were first standardized against a pro-oestrus sample that was included on all gels and then normalized against the highest mean value for each data set to eliminate reference to the external standard. Data were analysed by ANOVA using Duncan's multiple-range test. Columns that do not share a common letter are significantly different (P < 0.05). The molecular mass (× 10 − 3 ) markings corresponding to 120 and 130 kDa are shown to the left of the western blots. PBS-GM refers to control animals injected with PBS and gelatin instead of gonadotrophins that were killed at the same time as P/hCG-72 rats; eCG refers to animals killed at 48 h after eCG injection; P/hCG-24 and P/hCG-72 refer to rats killed at 24 and 72 h, respectively, after hCG injection of the eCG-treated rats. The expected occurrence of ovulation in response to this treatment paradigm is indicated.
standard sample (pro-oestrous extract of rat ovary) that was included on each gel (Machell et al., 2000) . This procedure allowed comparison between samples run on different gels and corrected for differences in background levels. Each value was then calculated as a percentage of the mean peak value (the highest mean value for the data set). Data were analysed by ANOVA and multiple comparisons were made using Duncan's multiplerange test with a significance level of P < 0.05. The mean daily progesterone production by cultured granulosa cells was compared between the hCG-treated and untreated cell cultures using one-tailed t tests and a significance level of P < 0.05.
Results
Ovarian expression of E-and N-cadherin in gonadotrophin-treated rats
Ovulation and luteinization were induced in the ovaries of immature rats by eCG and hCG treatments. Representative E-and N-cadherin immunoblots from the ovaries of these rats are shown (Fig. 1) . The means ( ± SEM) derived from the densitometric analyses of four separate immunoblots for each cadherin are shown ( Fig. 1) .
Treatment with eCG led to a significant, approximately threefold, increase in the expression of ovarian Ecadherin compared with that of control rats that received PBS-GM ( Fig. 1a ). There was no change in the ovarian content of E-cadherin protein at 24 h after hCG administration in eCG-primed rats, but by 72 h after hCG treatment, E-cadherin decreased to amounts comparable to those seen in the PBS-GM control rats. In contrast, ovarian N-cadherin was unaffected by eCG treatment (Fig. 1b) . However, N-cadherin increased significantly at 24 h after hCG administration and this increase was maintained at 72 h after hCG treatment. Examination of ovarian morphology at 48 h after eCG treatment showed the presence of many large antral and preovulatory follicles ( Fig. 2a) . At 24 h after hCG administration to these rats, many large follicles were observed together with recently ovulated follicles (Fig. 2b) . Well-formed corpora lutea were visible at 72 h after hCG treatment (Fig. 2c) .
Immunofluorescent staining for E-cadherin in eCGtreated rats revealed expression in thecal-interstitial cells, but staining was limited or in low amounts in granulosa cells of large antral follicles (Fig. 2d ). After treatment with hCG, cells in recently ovulated follicles were weakly stained for E-cadherin ( Fig. 2e) . The breakdown of the basement membrane was apparent as the autofluorescent red blood cells in the luteinizing follicle were visible (Paterakis, 1996) . By 72 h after treatment with hCG, the corpora lutea were brightly stained for E-cadherin (Fig. 2f ) .
N-cadherin immunostaining was present in thecalinterstitial cells and in granulosa cells of follicles of eCG-treated rats (Fig. 2g ). Staining appeared brighter in granulosa cells of preovulatory follicles compared with the smaller antral follicles (Fig. 2g ). N-cadherin staining was decreased in the cells of the luteinizing follicles at 24 h after hCG treatment (Fig. 2h) , as was the case for E-cadherin, but N-cadherin stained brightly in the corpora lutea (Fig. 2i ). Incubation of ovarian sections from gonadotrophin-treated or cyclic rats (see below) with non-specific mouse IgG or with the secondary antibody were not stained (not shown). The bottom panels are graphical representations derived from the densitometric analyses of similar western blots from four separate groups of rats at similar stages of the ovarian cycle. Densitometric values were first standardized against a pro-oestrus sample that was included on all gels and then normalized against the highest mean value for each data set to eliminate reference to the external standard. The expected occurrence of ovulation, with respect to the oestrous cycle, is shown. Data were analysed by ANOVA using Duncan's multiple-range test and were considered significantly different at P < 0.05. Columns with different letters are significantly different.
Ovarian E-and N-cadherin in cyclic rats
Ovaries from adult cyclic rats were examined to assess the effects of the cyclic changes in endogenous hormones on ovarian cadherins. Representative E-and N-cadherin immunoblots derived from ovary extracts of cyclic rats are shown (Fig. 3) . The means ( ± SEM) derived from the densitometric analyses of four individual immunoblots for each cadherin are shown (Fig. 3) .
The highest expression of E-cadherin was observed at dioestrus. This high expression was reduced by approximately 50% at pro-oestrus and reduced further at oestrus to approximately 15% of expression at dioestrus. Expression of E-cadherin at metoestrus was higher than at oestrus, but was still significantly lower than expression at dioestrus. Only the expression of E-cadherin at oestrus and metoestrus was significantly different from expression at dioestrus (Fig. 3a) .
Expression of N-cadherin showed a marked and significant increase between pro-oestrus and oestrus. This increase in expression was followed by a decline at metoestrus and then a slight increase at dioestrus. Note that the expression patterns for N-and E-cadherin during the oestrous cycle are different. E-cadherin shows a progressive increase starting from a nadir at oestrus (when N-cadherin is maximum) to maximal E-cadherin expression at dioestrus. In contrast, an increase in N-cadherin expression is seen at oestrus and dioestrus.
Evaluation of ovaries from cyclic rats showed staining for E-cadherin in extrafollicular cells including the surface epithelium, theca-interstitial cells and corpora lutea (Fig. 4a,b for metoestrous ovaries; data not shown for other cycle stages). N-cadherin was present in granulosa cells, the surface epithelium, portions of the theca-interstitium (Fig. 4c) , as well as in oocytes (not shown). N-cadherin staining was pronounced in the corpus luteum (Fig. 4d ). No obvious differences in staining distribution for either E-or N-cadherin were observed between ovaries collected at different stages of the oestrous cycle.
E-cadherin in granulosa cells luteinized in vitro
Progesterone production in vitro for granulosa cells derived from eCG-treated rats is shown (Fig. 5 ). Cells cultured with hCG showed a significant increase in progesterone production compared with cells cultured without hCG. This difference was seen only after 1 day 5 . Progesterone production in vitro by luteinizing granulosa cells. Granulosa cells, isolated from equine chorionic gonadotrophin (eCG)-treated prepubertal rats, were cultured in either the absence () or presence ( ) of 1 iu hCG for 3 days. Progesterone production was assessed each day by measurement of the progesterone concentration in the media. The data points illustrate the mean ( ± SEM) progesterone concentration for cultures of granulosa cells derived from eight eCG-treated rats. Each rat provided cells for at least four separate cultures which were assigned, in duplicate, to the two treatment groups. The mean daily progesterone production was compared between the two treatment groups using a one-tailed t test. Significant differences between the two treatment groups are indicated by an asterisk (P < 0.05).
in culture and persisted over the entire 3 day culture period. After 3 days in culture, granulosa cells treated with hCG acquired an enlarged, flattened appearance with a high cytoplasm to nucleus ratio and the presence of several cell extensions. In contrast, untreated granulosa cells maintained their smaller, rounded appearance (data not shown). Evaluation of N-and E-cadherin expression in the cultured granulosa cells is shown (Fig. 6 ). N-cadherin protein was present in residual ovarian tissue from PBS-GM rats as well as in granulosa cells derived from rats that received PBS-GM and eCG-treated rats, and from granulosa cells luteinized in culture (Fig. 6a) . RT-PCR analysis, with primers specific for E-cadherin, showed the presence of PCR products in ovarian residual tissue and luteinized granulosa cells, but not in granulosa cells from rats that received PBS-GM or rats treated with eCG ( Fig. 6b) . Western blot analysis for E-cadherin expression are in agreement with the PCR data (Fig. 6c ). The absence of an E-cadherin signal in the western blots for the PBS-GM and eCG derived granulosa cells is not due to the lack of protein since subsequent re-probing for ␤-catenin revealed similar amounts of this cadherin-associated protein in all of the lanes of the immunoblot (data not shown). Fig. 6 . E-cadherin is expressed in vitro by luteinizing rat granulosa cells. (a) Western blot analysis for expression of Ncadherin (approximate molecular mass of 130 kDa) protein in total extracts derived from ovarian residual tissue (RT) and granulosa cells from rats injected with PBS containing 0.1% (w/v) gelatin (GC), granulosa cells from rats treated with equine chorionic gonadotrophin (eCG) (GC-P) and granulosa cells from rats treated with eCG after 3 days in culture with 1 iu hCG ml −1 (GC-L).
(b) The results for RT-PCR analysis of RNA derived from ovarian residual tissue and granulosa cells corresponding to the same treatments. PCR was conducted using specific primers for Ecadherin, which yield an expected product of 432 bp. The amplified products were visualized on a 1% (w/v) agarose gel stained with ethidium bromide. (c) Western blot analysis for expression of E-cadherin (approximate molecular mass of 120 kDa) in total extracts of ovarian residual tissue and granulosa cells derived from the same treatment groups.
Discussion
The establishment of cell associations and interactions is an important component of tissue morphogenesis and development. The ovary, perhaps more than other organs, exemplifies such events. Changes in cell associations and segregation of cell populations are characteristics of follicular development, ovulation and formation of the corpus luteum (Hirshfield, 1991; Murphy, 2000) . Machell et al. (2000, 2002) described classical and atypical cadherin expression in the prepubertal rat ovary. These cadherins are expressed within specific compartments of the ovary and their expression shows changes during the different stages of follicular development. The present study reports expression of Eand N-cadherin in preovulatory follicles and during corpus luteum formation. The results demonstrate that changes in expression of cadherin accompany the formation and consolidation of follicular-lutein cells in the corpus luteum. In addition, the present study demonstrates that functional luteinization of isolated rat granulosa cells is accompanied by repeated expression of E-cadherin in these cells. Together, these observations further support the contention that remodelling and differentiation processes in the ovary involve modulation of cadherin expression.
The results of the present study indicate that enhanced expression of E-cadherin is an important event in the early stages of luteinization. Expression of ovarian E-cadherin increased after eCG treatment and remained high after hCG-induced ovulation. However, on the basis of immunofluorescence evaluation, the types of cell contributing to the enhanced expression of ovarian E-cadherin differ as a consequence of these hormone stimulations. The eCG-mediated increase in expression arises from the theca-interstitial cells surrounding enlarged preovulatory follicles. However, with induction of ovulation it appears that both the luteinizing theca and granulosa cells contribute to ovarian E-cadherin content. The expression of E-cadherin by luteinizing granulosa cells was confirmed in vitro when these cells were induced to express this CAM and produce progesterone in response to hCG.
The results from the present study with respect to the expression of E-cadherin in luteinizing follicles are not in agreement with the findings of Sundfeldt et al. (2000) . Sundfeldt et al. (2000) reported an abrupt decrease in ovarian E-cadherin protein within 4 h after hCG treatment of eCG-treated rats. This low expression of E-cadherin was maintained for up to 12 h after the hCG treatment. In contrast, a decrease in E-cadherin occurred only by 72 h after hCG treatment. Immunostaining results of the present study demonstrated the presence of E-cadherin in the luteo-follicular complex 24 h after hCG treatment, indicating that the luteinizing theca and granulosa cells were positive for this cadherin. Differences in tissue fixation procedures and the use of antigen retrieval may explain the ability to detect E-cadherin more readily in the tissue sections in the present study. There are also differences in the time intervals after hCG that were examined versus those examined by Sundfeldt et al. (2000) . In addition, a membraneenriched fraction of the ovarian homogenates was used for immunoblotting purposes, whereas these were not used in other studies. It is possible that there is an acute decrease in E-cadherin expression which is restored by 24 h. This finding raises the possibility that there may be two competing drives for E-cadherin expression in follicular, specifically, luteinizing theca cells. Initially, the downregulation of E-cadherin may be involved in facilitating the migration of theca cells into the ovulated follicle. The absence of E-cadherin has been associated with cell migratory behaviour (Streit et al., 1996) . The subsequent increase in E-cadherin could be involved in promoting adhesion between luteal cells leading to the consolidation of the corpus luteum.
Western blot analysis revealed that eCG treatment does not change ovarian N-cadherin content, although immunofluorescence indicated more intense staining of the membrana granulosa in preovulatory follicles. Failure to detect changes in ovarian N-cadherin is a consequence of the more general distribution of N-cadherin in the ovary (Machell et al., 2000) . Thus, small increases in expression in a subset of follicles, apparent by immunostaining, may not be detected as a change in total ovarian content. However, ovulation at oestrus or as a result of hCG treatment evokes an increase in Ncadherin indicating that luteinization is accompanied by increases in N-cadherin expression that may be related to luteal cell hypertrophy and hyperplasia. The increase in the expression of N-cadherin is maintained with the formation of the corpus luteum at 72 h after hCG administration.
As expected, western blot analyses reveal differences between gonadotrophin-treated and cyclic animals. The variations are due, most likely, to differences in composition between the ovaries from the two groups (for example, the presence of corpora lutea from previous cycles and degenerating follicles in the adults). One of the advantages of using gonadotrophin-treated immature animals is that degenerating corpora lutea or corpora lutea from previous cycles are not present in the ovary. In addition, events can be followed in a temporal manner on the basis of the time of administration of the gonadotrophins.
The observed changes in the expression of cadherin in the gonadotrophin-treated animals indicate that ovarian E-and N-cadherin are affected in different ways by hormones. Oestrogen can regulate E-and N-cadherin mRNA content in the mouse ovary (MacCalman et al., 1994b (MacCalman et al., , 1995 and N-cadherin in granulosa cells (Farookhi et al., 1997) . The presence of E-cadherin mRNA and protein in luteinized granulosa cells indicates that LH may be involved in transcriptional regulation of this cadherin in granulosa-lutein cells. In human cultured cytotrophoblasts, hCG alters cadherin expression (Shi et al., 1993) . Expression of E-cadherin may be dependent on concentrations of progesterone. The experimental design used in the present study does not allow distinction between gonadotrophin or progesterone dependence. E-cadherin is regulated by both oestrogen and progesterone in reproductive tissues (MacCalman et al., 1994a,b; Potter et al., 1996) .
The immunostaining results of the present study indicate that similar changes in the expression of Eand N-cadherin occur during corpus luteum formation regardless of whether the luteinization process is evoked by exogenous gonadotrophin treatment or as the consequence of changes in endogenous cyclic hormone. Considering that luteal E-and N-cadherin expression has been demonstrated in other species (that is humans and baboons) (Khan-Dawood et al., 1996a,b; Makrigiannakis et al., 2000) , their role in corpus luteum organization may be general across mammalian species.
In summary, the present study has demonstrated that the expression of two classic cadherins (E-and Ncadherin) is modulated during the periovulatory period and formation of the corpus luteum in gonadotrophintreated immature and adult cyclic rats. In addition, granulosa cells express E-cadherin after in vitro luteinization. These results, in association with previous studies, provide compelling evidence that expression of cadherin in the ovary is hormonally regulated and is an important component of ovarian function.
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